Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 34 filings·Updated 30 Sept 2026
Showing 10 of 34 filings.
30 Sept 20261 filing
Company UpdateGeneral

Bandaram Pharma Packtech board meeting cancelled for 30 September 2026

Board meeting update

  • Board of Directors meeting scheduled for 30 September 2026 stands cancelled due to unavoidable reasons.
Filed 18:05View Source
26 Sept 20261 filing
Board Meeting

Bandaram Pharma Packtech to hold board meeting on 30 Sep 2026 to consider scheme of arrangement; trading window to close from 27 Sep 2026

Meeting Details

  • Board to meet on 30 September 2026 at the registered office.

Key Agenda Items

  • Proposal for scheme of Arrangement/Amalgamation to be considered.
  • Any other business with permission of the Chair.

Other Notes

  • Trading window closes from 27 September 2026 until 48 hours after outcome declaration.
Filed 20:57View Source
24 Sept 20262 filings
AGM/EGMAGM

Bandaram Pharma Packtech AGM for FY2025-26 held via VC/OAVM on 24 Sep 2026 at 11:08 IST; Scrutinizer's Report submitted

AGM details

  • AGM held on 24 September 2026 at 11:08 A.M. IST via VC/OAVM.

Documentation

  • Scrutinizer's report submitted pursuant to Section 108 and Rule 20(4)(xii).
Filed 16:15View Source
AGM/EGMAGM

Bandaram Pharma Packtech holds AGM via OAVM; resolutions include financial statements and director re-appointments.

AGM details

  • AGM held on 24 Sep 2026 at 11:08 a.m. via VC/OAVM; concluded 11:24 a.m.

Resolutions

  • Ordinary: adopt standalone financial statements for year ended 31 March 2026.
  • Ordinary: adopt consolidated financial statements for year ended 31 March 2026.
  • Ordinary: re-appoint director retiring by rotation.
  • Ordinary: re-appoint statutory auditors.
  • Special: re-appoint independent director.

Voting results

  • Voting conducted via remote e-voting and AGM; outcome details not disclosed in excerpt.

Director changes

  • Director retiring by rotation proposed for re-appointment.
  • Independent director re-appointed.

Auditor appointments

  • Statutory auditors re-appointed.
Filed 16:10View Source
22 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Bandaram Pharma Packtech Limited: Trading window closed from 01.10.2026 till 48 hours after the declaration of standalone and consolidated unaudited Financial Results for the quarter and half-year ended 30.09.2026

Bandaram Pharma Packtech Limited: Trading window closed from 01.10.2026 till 48 hours after the declaration of standalone and consolidated unaudited Financial Results for the quarter and half-year ended 30.09.2026

Filed 14:43View Source
1 Sept 20261 filing
OthersReg. 34 (1) Annual Report

Bandaram Pharma Packtech FY2025-26: Standalone loss; consolidated revenue Rs 6,292.32 Lakhs; two subsidiaries; no dividend.

Financial performance

  • Standalone revenue from operations: Rs 1,095.99 Lakhs.
  • Standalone net loss: Rs 116.05 Lakhs.
  • Consolidated revenue from operations: Rs 6,292.32 Lakhs.
  • Consolidated net profit after tax: Rs 28.12 Lakhs.
  • No dividend recommended or paid for FY2025-26.

Capital structure & equity

  • Authorised share capital raised to Rs 19 Crores.
  • Paid-up capital after preferential issue: Rs 17.97 Crores.
  • 59,71,920 equity shares issued for Craftsmart swap.
  • Craftsmart became wholly owned subsidiary.
  • No debt raised; corporate guarantees extended to subsidiaries.

Subsidiaries & group structure

  • Two material subsidiaries: Craftsmart (100%); VSR Paper & Packaging Limited (Bandaram holds 51.08%).
  • Craftsmart turnover Rs 136.40 Lakhs; net loss Rs 45.82 Lakhs.
  • VSR Paper & Packaging Limited turnover Rs 5313.08 Lakhs; PAT Rs 149.12 Lakhs.
  • Consolidated non-controlling interest: Rs 458.47 Lakhs.
  • Craftsmart is wholly owned; VSR is a subsidiary with majority control.

Governance & audit

  • Independent Director Suryaprakasa Bommisetti reappointed for 5 years from 07.03.2027.
  • Ms. Mounika Pammi appointed Independent Director w.e.f 20.06.2025.
  • Auditors M.M. Reddy & Co.; proposed reappointment for 3-year term to 2029-30 at Rs 2,00,000 p.a.
  • Secretarial auditor: Manoj Parakh & Associates.
  • Board meetings held: 10 in the year.

Related party transactions

  • Material RPTs: Corporate guarantees Rs 25 Crores to VSR; Rs 5 Crores to Craftsmart.
  • Intercompany sales/purchases with subsidiaries: VSR Rs 129.29 Lakhs; Craftsmart Rs 100.89 Lakhs.
  • Share swap acquisition: 59.71 Lakh equity shares issued.
  • RPTs reviewed and approved by Audit Committee; disclosed in Form AOC-2.

Audit flags & controls

  • Consolidated report includes a qualification due to set-off of sundry debtors/creditors in VSR.
  • Emphasis of matter: trade receivables ageing not disclosed; recoverability assessed by management.
  • MD and CFO certification attached; internal controls deemed adequate.
  • Secretarial audits present without adverse qualifications.

Outlook & risks

  • Outlook favorable for India's paper recycling market and packaging demand.
  • Risks include high operating costs and need for ongoing capex.
  • Liquidity risk managed by promoter funding as required.

Management disclosures & compliance

  • MD/CFO certification and corporate governance disclosures incorporated in annual report.
  • Corporate governance deemed compliant with SEBI LODR norms as of FY2025-26.
  • MCAs and SEBI circulars referenced for VC/OAVM AGM and e-voting arrangements.
Filed 18:10View Source
13 Aug 20261 filing
ResultFinancial Results

Bandaram Pharma Packtech Q2 FY2026: standalone loss Rs 35.68 lakh; consolidated profit Rs 68.44 lakh.

Standalone quarterly results

  • Standalone Q2 30.06.2026 revenue from operations: Rs 298.51 lakh.
  • Standalone Q2 30.06.2026 PBT: Rs -35.68 lakh.
  • Standalone Q2 30.06.2026 PAT: Rs -35.68 lakh.
  • Standalone Q2 30.06.2026 EPS (basic/diluted): Rs -0.20.

Consolidated quarterly results

  • Consolidated Q2 30.06.2026 revenue from operations: Rs 2,395.26 lakh.
  • Consolidated Q2 30.06.2026 PBT: Rs 92.49 lakh.
  • Consolidated Q2 30.06.2026 PAT: Rs 68.44 lakh.
  • Consolidated continuing EPS (basic): Rs 0.11; diluted: Rs 0.05.

Corporate actions & AGM

  • Independent Director Bommisetti reappointed for 2nd term from 07.03.2027.
  • Auditors M/s M.M. Reddy & Co. reappointed for 3 years.
  • Board approved unaudited results for Q2 2026 on 13 Aug 2026.
  • AGM scheduled 18.09.2026 via video conference.

Notes

  • Ind AS 34 interim reporting; results reviewed by statutory auditors.
  • Consolidated results include unaudited figures of VSR Paper & Craftsmart.
Filed 18:22View Source
6 Aug 20261 filing
Board Meeting

Bandaram Pharma Packtech to hold 13 August 2026 board meeting to review Q1 unaudited results

Meeting Details

  • Board meeting scheduled for 13 August 2026 at the registered office.

Key Agenda Items

  • Un-audited standalone and consolidated financial results with Limited Review Report for quarter ended 30.06.2026.
  • Any other business with the permission of the Chair.

Other Notes

  • Trading window closed from 01 July 2026 until 48 hours after the unaudited Q1 30 June 2026 results.
Filed 16:09View Source
11 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate confirms dematerialisation processing, listing, and registered owner update

Dematerialisation processing & records

  • Dematerialisation requests processed; securities listed on exchanges; certificates mutilated and cancelled; depository name substituted as registered owner.
Filed 13:18View Source
7 Jul 20261 filing
Company UpdateGeneral

Bandaram Pharma Packtech reports no material events or price-sensitive information

Movement in Price

  • No price-sensitive events or information; no extraordinary events occurred; will inform the Exchange if arising.
Filed 17:38View Source
Showing 10 of 34 filings